Clinical markers of endometriosis: Have we been too quick to judge?

K Toor; Jocelyn M. Wessels; J M Wessels; Sanjay K. Agarwal; S K Agarwal; N Leyland; Nicholas Leyland; Warren G. Foster; W G Foster

doi:10.1016/j.mehy.2014.02.007

Clinical markers of endometriosis: Have we been too quick to judge?

K Toor, Jocelyn M. Wessels, J M Wessels, Sanjay K. Agarwal, S K Agarwal, N Leyland, Nicholas Leyland, Warren G. Foster, W G Foster

Medical hypotheses · 2014 · vol. 82(4) , pp. 493–501 · doi:10.1016/j.mehy.2014.02.007 · PMID:24559691 · W2015451974

review OA: closed CC0 ⤵ 9 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This paper critically examines the current clinical markers for endometriosis, questioning whether their assessment has been premature.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715mesh:D017699endometriosis

MeSH descriptors

Endometriosis Endometriosis Pelvic Pain Biomarkers Biomarkers Endometriosis Female Humans Inflammation Models, Theoretical Pain Measurement Pelvic Pain Quality of Life Research Design Surveys and Questionnaires

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (94)

Cited by (9)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:18:35.150238+00:00

License: CC0 · commercial use OK

[1] Advances in the medical management of endometriosis via openalex

[2] Advances in the medical management of endometriosis via openalex

[3] An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients via openalex

[4] Apoptosis pattern in human endometrium in women with pelvic endometriosis via openalex

[5] Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients via openalex

[6] Association of interleukin‐6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis via openalex

[7] Biomarkers of endometriosis via openalex

[8] Brain-derived neurotrophic factor in plasma of women with endometriosis via openalex

[9] Brain-Derived Neurotrophic Factor in Plasma of Women with Endometriosis via openalex

[10] Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis via openalex

[11] Chronic Pelvic Pain and Quality of Life in Women with and without Endometriosis via openalex

[12] Combination of CCR1 mRNA, MCP1, and CA125 Measurements in Peripheral Blood as a Diagnostic Test for Endometriosis via openalex

[13] Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis via openalex

[14] Concentration of soluble intercellular adhesion molecule-1 in serum samples from patients with endometriosis collected during the luteal phase of the menstrual cycle via openalex

[15] Concentrations of Alpha-Fetoprotein, Insulin-Like Growth Factor Binding Protein-3, c-erbB-2, and Epidermal Growth Factor in Serum of Patients With Endometriosis via openalex

[16] Concentrations of interleukin (IL)-1α, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis via openalex

[17] Coordinated but depressed expression of human leukocyte antigen-DR, intercellular adhesion molecule-1, and CD14 on peritoneal macrophages in women with pelvic endometriosis via openalex

[18] Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis via openalex

[19] Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis via openalex

[20] Density of small diameter sensory nerve fibres in endometrium: a semi-invasive diagnostic test for minimal to mild endometriosis via openalex

[21] Diagnosis of endometrial nerve fibers in women with endometriosis via openalex

[22] Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis via openalex

[23] Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis via openalex

[24] Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis via openalex

[25] Endometriosis: cost estimates and methodological perspective via openalex

[26] Endometriosis: Expression of the 60 kDa heat shock protein in peritoneal fluids from women with endometriosis: implications for endometriosis-associated infertility via openalex

[27] EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex

[28] ESHRE guideline for the diagnosis and treatment of endometriosis via openalex

[29] Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells via openalex

[30] Etiology and epidemiology of endometriosis via openalex

[31] Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis via openalex

[32] Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis via openalex

[33] Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas via openalex

[34] Haptoglobin β chain isoforms in the plasma and peritoneal fluid of women with endometriosis via openalex

[35] High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis via openalex

[36] High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis via openalex

[37] High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners via openalex

[38] High serum follistatin levels in women with ovarian endometriosis via openalex

[39] Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex

[40] Interleukin-12 but not interleukin-18 is associated with severe endometriosis via openalex

[41] Killer Inhibitory Receptor CD158a Overexpression Among Natural Killer Cells in Women With Endometriosis is Undiminished by Laparoscopic Surgery and Gonadotropin Releasing Hormone Agonist Treatment* via openalex

[42] Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis via openalex

[43] Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis via openalex

[44] Mass spectrometry and serum pattern profiling for analyzing the individual risk for endometriosis: promising insights? via openalex

[45] Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis via openalex

[46] Measurable serum markers of oxidative stress response in women with endometriosis via openalex

[47] MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis via openalex

[48] Multiple endometrial antigens are targeted in autoimmune endometriosis via openalex

[49] Nerve Fibers are Absent in Disease-Free and Eutopic Endometrium, but Present in Endometriotic (Especially Deep) Lesions via openalex

[50] Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting via openalex

[51] Peripheral biomarkers of endometriosis: a systematic review via openalex

[52] Peritoneal fluid and serum concentration of interleukin-16 in women with endometriosis via openalex

[53] Peritoneal fluid and serum leptin concentrations in women with primary infertility via openalex

[54] Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis via openalex

[55] Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis via openalex

[56] Plasma Urocortin Levels in the Diagnosis of Ovarian Endometriosis via openalex

[57] Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis via openalex

[58] Prolactin and cortisol levels in women with endometriosis via openalex

[59] Proteomic identification of neurotrophins in the eutopic endometrium of women with endometriosis via openalex

[60] Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex

[61] Serum adiponectin concentrations are decreased in women with endometriosis via openalex

[62] Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours via openalex

[63] Serum Antiendometrial Antibodies and Diagnosis of Endometriosis via openalex

[64] Serum CA-125 in the diagnosis of endometriosis via openalex

[65] Serum interleukin-8 levels are elevated in patients with ovarian endometrioma via openalex

[66] Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease via openalex

[67] Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: No association with advanced endometriosis via openalex

[68] The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex

[69] The impact of endometriosis upon quality of life: a qualitative analysis via openalex

[70] The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions via openalex

[71] Two novel serum biomarkers for endometriosis screened by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and their change after laparoscopic removal of endometriosis via openalex

[72] Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas via openalex

[73] Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report via openalex

[74] Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis via openalex

[75] What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis via openalex

[76] W2158381921 via openalex

[77] W2065390631 via openalex

[78] W2162110143 via openalex

[79] W2080420959 via openalex

[80] W1996855651 via openalex

[81] W1996294949 via openalex

[82] W2171863626 via openalex

[83] W2206304062 via openalex

[84] W2418185885 via openalex

[85] W2094067819 via openalex

[86] W2628053793 via openalex

[87] W2049037562 via openalex

[88] W1974617143 via openalex

[89] W2135721067 via openalex

[90] W2131501232 via openalex

[91] W2125052189 via openalex

[92] W2032494767 via openalex

[93] W2060293761 via openalex

[94] W2024150595 via openalex